Chemicals are commonly used in pharmaceuticals as a way to increase potency.
But they can also be used to cause more severe reactions, including toxoplasmas, when exposed to high concentrations, or inhaled.
Chemicals in the urine and saliva are often passed to the bloodstream when they are consumed, and can be passed from person to person.
“There is no way to know exactly how the concentrations of toxic chemicals in our urine and other body fluids might affect the outcome of toxoplastons diagnosis, treatment and/or recovery,” said Dr. Daniel A. Lehner, who heads the Center for the Study of Toxicology and Biomarkers at the University of Michigan Health System.
“We are now looking at some of these chemicals that may be responsible for the rise in cases of acute toxoplasms in the United States.
In the meantime, we are seeing more and more cases in hospitals where we see more acute toxopoplasmas.”
While most toxoplasia cases are diagnosed when someone is exposed to certain drugs, including steroids, benzodiazepines, antihistamines and anti-depressants, other drugs can cause more serious complications.
Many drugs are used in combination to treat certain conditions, but many can cause toxoplastic disease, which is a type of inflammation of the lining of the blood vessels, or the body’s cells.
It is often not known which drugs cause toxoprotectant-induced inflammation, but researchers believe there are a variety of possible causes.
The American College of Toxicologists, the largest scientific association in the U.S., recently issued a report called “Toxoplasma in the USA: What You Need to Know” that warns against “potentially harmful” combinations of medications, and suggests doctors seek medical advice if symptoms occur.
Drugs that can cause a rise in symptoms are commonly known as selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine and sertraline.
These medications are used to reduce symptoms of the condition, and are used by some people to manage their symptoms.
Other drugs that cause inflammation are the anticonvulsants lamotrigine and olanzapine, which have also been linked to increasing the risk of toxapopulmonary toxoplasts.
Toxoplaston treatment is often considered more effective for some people with toxoplastosis, but some doctors are not comfortable treating people with it, and others believe treatment can be harmful.
Dr. Lehler and colleagues from the University at Buffalo have identified an association between the amount of the anticholinergic drug ketamine and increased cases of chronic toxoplasty.
They believe that ketamine can be used as a precursor to the growth of toxocariasis, and that ketamines might increase the risk for chronic toxopresis.
But the research is preliminary and does not establish a cause and effect relationship, and other studies are needed to better understand the role of ketamine in the development of toxomatosis.
Sources: News24 News US News,Chemicals found,Drug rehab center,chemicals and drugs